Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

Card image cap
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Rapid Free Communications

Fetal and Neonatal Endocrinology

hrp0098rfc14.1 | Fetal and Neonatal Endocrinology | ESPE2024

The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life.

Righi Beatrice , Alberghi Francesca , Pelosi Annalisa , Fontana Marta , Sartori Chiara , Davolio Emanuela , Rotteglia Cecilia , Catellani Cecilia , Buia Veronica , Shulhai Anna-Mariia , Paterlini Silvia , De Fanti Alessandro , Nuti Francesca , Real Fernandez Feliciana , Fanos Vassilios , Maria Papini Anna , Palanza Paola , Elisabeth Street Maria

Introduction: The ongoing LIFE-MILCH project (www.lifemilch.eu), focuses on detecting EDCs in mothers, in breast milk (BM) and in urine, and in infants from birth up to 12 months of age studying relationships with neurodevelopment, growth, distribution of adiposity, pubertal stages, and ano-genital distances, life-style sources (questionnaires) of exposure to establish a risk assessment model to prepare safety guide...

hrp0098rfc14.2 | Fetal and Neonatal Endocrinology | ESPE2024

Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?

Abali Saygin , Oz-Arslan Devrim , Guner-Yilmaz Bengisu , Celik Musa , Koç Berkcan , Muftuoglu Meltem , Pata Ozlem , Korkmaz-Toygar Ayse , Semiz Serap , Kan Beki , Beken Serdar

Introduction: Gestational diabetes mellitus (GDM) is a common problem in pregnancy with metabolic consequences for the fetus and the postnatal period. The aim of this study was to investigate the effects of GDM on mitochondrial structure and function in cord blood mononuclear cells and placental tissue, and the relationship between clinical data and mitochondrial dynamics.Method: In this prospective cohort study, singlet...

hrp0098rfc14.3 | Fetal and Neonatal Endocrinology | ESPE2024

Complex Glycerol Kinase Deficiency: four new cases and a review of the literature

Wang Fengxue , Shang Xiaohong , Li Guimei

Objective: Complex glycerol kinase deficiency (CGKD) is a rare genetic syndrome which belongs to the group of contiguous gene syndromes and is caused by microdeletion of genes located in Xp21, which also be called Xp21 contiguous gene deletion syndrome. Patients with CGKD present with features characteristic for adrenal hypoplasia congenita (AHC), glycerol kinase deficiency (GKD), Duchenne muscular dystrophy (DMD) and sometimes intellectual disability or hyper...

hrp0098rfc14.4 | Fetal and Neonatal Endocrinology | ESPE2024

Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant.

Pujari Divya , Conlon Alison , Wakeling Emma , Houghton Jayne , Flanagan Sarah , Eldred Carey , Starling Luke , Kaliakatsos Marios , Dastamani Antonia

Introduction: Congenital hyperinsulinism (CHI) is a rare condition often caused by variants in genes that regulate insulin production. Among the 30 genes identified, CACNA1D, which encodes L-type calcium channels in various cells, is a rare cause. Variants in CACNA1D lead to a multisystem disorder characterized by developmental delay, intellectual disability, autism, hypotonia, seizures, primary aldosteronism, CHI, hearing loss, visual issues...

hrp0098rfc14.5 | Fetal and Neonatal Endocrinology | ESPE2024

The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation.

Whitehead Jennifer , Worth Chris , Beeston Helen , Hird Beverly , Banerjee Indraneel

Background: Congenital hyperinsulinism (HI) results in hyperinsulinemic hypoglycaemia in infants; a significant risk factor for brain injury due to neuroglycopenia and the suppression of alternative neuroprotective mechanisms such as ketogenesis. Neuronal damage can occur in both transient and persistent HI, with worse neurodevelopmental outcomes reported in those who receive a delayed diagnosis. There is currently no method for screening for HI and neuronal d...

hrp0098rfc14.6 | Fetal and Neonatal Endocrinology | ESPE2024

Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism

De Silva Shamani , Worth Chris , Worthington Sarah , O'Shea Elaine , Salomon-Estebanez Maria , Banerjee Indraneel

Introduction: Patients with hyperinsulinism suffer recurrent and severe hypoglycaemia. Inpatient glucose monitoring is currently via intermittent, infrequent fingerprick self-monitoring blood glucose (SMBG), and risks missing hypoglycaemia between tests. Continuous glucose monitoring (CGM) offers a supplementary therapy which may identify unexpected hypoglycaemia and ultimately reduce total exposure. However, CGM has never been evaluated for its efficacy in th...